The U.S. Centers for Disease Control and Prevention (CDC) has revised its guidance on COVID-19 vaccines for children, stating that vaccination for healthy individuals aged 6 months to 17 years should follow a “shared clinical decision-making” process. This means that shots are still available, but only if parents and doctors agree it's necessary based on individual circumstances.
The move marks a shift from earlier CDC guidance, which broadly recommended updated COVID-19 vaccines for everyone six months and older. The updated schedule, published Thursday, outlines that if parents want their child vaccinated, they may proceed based on a healthcare provider’s judgment and the family’s preference.
Health Secretary Robert F. Kennedy Jr., a known vaccine skeptic, claimed earlier in the week that COVID vaccines for healthy children and pregnant women had been removed from the CDC’s immunization schedule. However, a Department of Health and Human Services spokesperson said there is no contradiction, as the CDC’s updated guidance no longer promotes universal vaccination for healthy children but still allows it case-by-case.
Medical experts criticized Kennedy’s unilateral announcement, saying it bypassed the CDC’s usual advisory process. The Infectious Diseases Society of America warned the change may limit access and insurance coverage, especially for vulnerable children. They emphasized that COVID-19 can cause serious illness in children, including long COVID symptoms that may impact development.
According to CDC data, nearly 1,900 children under 18 have died from COVID-19 in the U.S. as of 2023. Vaccine makers Pfizer, Moderna, and Novavax have not commented on the development.
The FDA also recently announced it would require new clinical trials for annual COVID boosters in healthy individuals under 65, reinforcing a more limited use strategy moving forward.


India Plans Tax Reforms to Boost Foreign Investment and Manufacturing
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
AI Data Center Boom Faces New Risks as Public Backlash and Policy Scrutiny Grow
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Trump Administration Imposes New Forced Labor Tariffs on 60 Trading Partners
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Brazil Rejects Visas for Trump Officials Ahead of Presidential Election
Trump Orders Warning Signs Outside Smithsonian Museum Over ‘Anti-American’ Exhibits
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
US Embassies Urge Americans to Leave Middle East as Iran Tensions Escalate
Trump Education Department Removes Disparate Impact Rules, Sparking Civil Rights Backlash
FAA Proposes Inspections for Boeing 737 MAX Passenger Seats Over Installation Concern 



